SCHEMBL26967929

SCHEMBL26967929

Cc1cc(C)c([N+](=O)[O-])cc1N1CCCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ HTT P42858 3/20 0.53
▸ ALDH1A1 P00352 4/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ AKR1C3 P42330 1/20 0.44
▸ CYP3A4 P08684 3/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ MAPT P10636 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ MCOLN3 Q8TDD5 1/20 0.39
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11189883 0.96 HTT (0.49) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL11191394 0.91 HTT (0.43) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL85636 0.90 HTT (0.49) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL8372369 0.78 HPGD (0.61) KDM4EGAAHTTALDH1A1SMN1; SMN2
SCHEMBL24105032 0.78 TDP1 (0.55) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL30168136 0.78 TDP1 (0.55) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL17979815 0.78 TDP1 (0.51) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL11495637 0.77 CYP3A4 (0.43) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL11496149 0.77 HPGD (0.38) KDM4EGAAHTTALDH1A1HSD17B10
SCHEMBL11490102 0.77 ALDH1A1 (0.40) KDM4EGAAHTTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158348-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP FMC CORPORATION 2024-05-16 — — US disclosed
EP-4294791-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP FMC CORPORATION (US) 2023-12-27 — — EP disclosed
CN-116888097-A Haloalkyl sulfonamide anilino N-substituted herbicidal cyclic amides FMC公司 2023-10-13 — — CN disclosed
WO-2022177892-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP FMC CORPORATION (US) 2022-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158348-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP CBR3, NQO2, CBR1 KDM4E 1407/4885GAA 1532/4885HTT 2581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback